(PDF) Drug Development for Neglected Diseases: A Deficient

Drug Development for Neglected Diseases: A Deficient Market and a Public-Health Policy Failure

The Lancet - United Kingdom

doi 10.1016/s0140-6736(02)09096-7

Full Text

Abstract

Available in full text

Categories

Date

June 1, 2002

Authors

Patrice Trouiller

Publisher

Elsevier BV

Related search

Sexually Transmitted Diseases: A Neglected Public Health Priority.

American Journal of Public Health

Occupational Health

English

Fungal Diseases as Neglected Pathogens: A Wake-Up Call to Public Health Officials

PLoS Neglected Tropical Diseases

Infectious Diseases

Occupational Health

English

A Multilayer Network Approach for Guiding Drug Repositioning in Neglected Diseases

PLoS Neglected Tropical Diseases

Infectious Diseases

Occupational Health

English

Innovative Partnerships for Drug Discovery Against Neglected Diseases

PLoS Neglected Tropical Diseases

Infectious Diseases

Occupational Health

English

Physical Activity Recommendations for Public Health: Development and Policy Context

English

Product Development Programs for Neglected Tropical Diseases: A Crucial Role for Expert Meetings

PLoS Neglected Tropical Diseases

Infectious Diseases

Occupational Health

English

Regulatory Policy for Research and Development of Vaccines for Public Health Emergencies

Expert Review of Vaccines

Molecular Medicine

English

Drug Shortage: A Public Health Problem

Cadernos de Saude Publica

Occupational Health

English

2020: A Crucial Year for Neglected Tropical Diseases

English